COGT — Cogent Biosciences Inc.

Ownership history in Knott David M Jr  ·  2 quarters on record

This page tracks every 13F SEC filing in which Knott David M Jr reported a position in Cogent Biosciences Inc. (COGT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.68% (2025 Q4)
Avg. % of fund
1.14%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 102,000 -111,302 -52.2% 1.68% $3.6M $35.52
2025 Q1 INITIATED 213,302 — — 0.60% $1.3M $5.99
% of Fund (quarterly)    COGT price (monthly, adj. close)

Other funds also holding COGT

As of 2025 Q4 — sorted by position size

Fairmount Funds Management LLC 3Y 24.34% Kynam Capital Management, LP 3Y 13.99% Elmind Capital, LP 12.27% Octagon Capital Advisors LP 3Y 10.13% Saturn V Capital Management LP 3Y 7.93% SUPERSTRING CAPITAL MANAGEMENT LP 6.96% TCG Crossover Management, LLC 3Y 6.9% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 6.14% Vivo Capital, LLC 3Y 7Y 5.51% Commodore Capital LP 3Y 5.19%
← Back to Knott David M Jr Holdings